Objective ： To observe the therapeutic effects of Yiqi Sanju Formula （YQSJF） ， a compound Chinese herbal medicine ， on central obese men at high risk of metabolic syndrome （MS） ． Methods ：Compared with ３０ healthy male volunteers ， ４５ central obese men were separated randomly into two groups and received the interventions with YQSJF and placebo respectively for １０ weeks ． Baseline characteristics ， insulin resistance ， inflammation cytokines and plasminogen activator inhibitor１ （PAI１） and tissue plasminogen activator （tPA） were evaluated before and after treatment ． Results ： The score of homeostatic model assessment for insulin resistance （HOMAIR） and the levels of C reactive protein （CRP） ， free fatty acid （FFA） and PAI１ in obese men were higher than those in the control group ， while tPA was lower ． After treatment ， compared with placebo group ，body mass index ，waist ， and waisttohip ratio were decreased significantly in subjects who received YQSJF （ P ＜ ０ ．０１） ． The score of HOMAIR and the levels of CRP ， FFA and PAI１ were decreased significantly ， and the level of tPA was increased significantly （ P ＜ ０ ．０１） ． Conclusion ： YQSJF can reduce obesity and insulin resistance in central obese men at high risk of MS and improve inflammation and fibrinolysis ， which indicates that it can reduce the risk of atherosclerosis ． Keywords ： metabolic syndrome ； obesity ； insulin ； traditional Chinese medicine Table 1 Common state before and after treatment
A ft e r tr eat m en t
  P ＜ ０ ．０ １ ， vs co n t r ol g r ou p ； △ △ P ＜ ０ ．０１ ， vs be fo r e t r ea tm e n t ； ▲ ▲ P Table 2 Changes of FBG ， TG and HOMAIR before and after treatment
Bef o re t r eat m en t ２２ ５ ．０３ ± ０ ．３９ １ ．３０ ± ０ ．３３ ２ ．６８ ± ０ ．８５   A ft e r tr eat m en t ２２ ５ ．１６ ± ０ ．３６ １ ．３９ ± ０ ．４１ １ ．７６ ± ０ ．６４ △ △ ▲ ▲
Placeb o
Bef o re t r eat m en t ２３ ５ ．０９ ± ０ ．３４ １ ．２６ ± ０ ．３３ ２ ．６６ ± ０ ．９２  
A ft e r tr eat m en t ２３ ５ ．２７ ± ０ ．４４ １ ．３６ ± ０ ．４２ ２ ．８９ ± １ ．４１   P ＜ ０ ．０ １ ， vs co n t r ol g r ou p ； △ △ P ＜ ０ ．０１ ， vs be fo r e t r ea tm e n t ； ▲ ▲ P ＜ ０ ．０１ ， v s p laceb o g r o up ． 表 3 治疗前后 CRP 、FFA 、PAI1 和 tPA 变化 Table 3 Changes of CRP ， FFA ， PAI1 and tPA before and after treatment
Bef o re t r eat m en t
A ft e r tr eat m en t ２ ３ ５ ．４ ８ ± ２ ．６６ ０ ．６１ ± ０ ．２２ ３ １ ．０ ５ ± １０ ．２ ４ １４ ．０１ ± ６ ．８０  P ＜ ０ ．０ ５ ，   P ＜ ０ ．０１ ， vs co n t r ol g r o up ； △ P ＜ ０ ．０ ５ ， △ △ P ＜ ０ ．０１ ， vs be fo r e tr ea t m e n t ； ▲ P ＜ ０ ．０５ ， ▲ ▲ P ＜ ０ 
